Demographics |
Age
|
23.3 (3.5) |
23.1 (3.3) |
23.8 (3.1) |
F(2, 190) = .70, p = .50 |
23.3 (3.3) |
BMI
|
22.7 (2.0) |
22.5 (2.3) |
22.5 (1.9) |
F(2, 190) = .16, p = .85 |
22.6 (2.1) |
Gender
|
Male |
34 (61%) |
45 (51%) |
22 (46%) |
χ2(1, 193) = 2.50, p = .29 |
101 (52%) |
Female |
22 (39%) |
44 (49%) |
26 (54%) |
|
93 (48%) |
Education
|
HS/GED |
2 (4%) |
1 (1%) |
1 (2%) |
χ2(6, 193) = 3.62, p = .73 |
4 (2%) |
Some Coll. |
19 (34%) |
31 (35%) |
15 (31%) |
|
65 (34%) |
BA/BS |
29 (52%) |
47 (53%) |
30 (63%) |
|
106 (55%) |
Graduate |
6 (11%) |
10 (11%) |
2 (4%) |
|
18 (9%) |
Current Drug Use |
Alcoholic drinks/week
|
5.4 (4.7) |
6.0 (5.0) |
5.0 (5.3) |
F(2, 190) = .43, p = .65 |
5.7 (4.8) |
Cigarettes/week
|
1.1 (2.6) |
1.1 (2.2) |
0.9 (2.2) |
F(2, 190) = 1.8, p = .84 |
1.0 (2.3) |
Cannabis uses/month
|
2.1 (5.8) |
1.9 (4.8) |
1.3 (3.8) |
F(2, 190) = .37, p = .70 |
1.8 (4.9) |
Lifetime Drug Use |
Cannabis
|
Never |
11 (20%) |
16 (18%) |
12 (25%) |
χ2(8, 193) = 11.33, p = .18 |
39 (20%) |
1–10x |
25 (45%) |
26 (29%) |
15 (31%) |
|
66 (34%) |
11–50x |
6 (11%) |
25 (28%) |
11 (23%) |
|
42 (22%) |
51–100x |
4 (7%) |
2 (2%) |
3 (6%) |
|
9 (5%) |
>100x |
10 (18%) |
20 (23%) |
7 (15%) |
|
37 (19%) |
Tranquilizers
|
Never |
51 (93%) |
79 (89%) |
43 (90%) |
χ2(4, 193) = 3.89, p = .42 |
173 (90%) |
1–10x |
4 (7%) |
7 (8%) |
5 (10%) |
|
16 (8%) |
11–50x |
0 (0%) |
3 (3%) |
0 (0%) |
|
3 (2%) |
Stimulants
|
Never |
41 (73%) |
60 (67%) |
36 (75%) |
χ2(8, 193) = 13.14, p = .11 |
137 (71%) |
1–10x |
10 (18%) |
23 (26%) |
7 (15%) |
|
40 (21%) |
11–50x |
4 (7%) |
5 (6%) |
1 (2%) |
|
10 (5%) |
51–100x |
0 (0%) |
0 (0%) |
3 (6%) |
|
3 (2%) |
>100x |
1 (2%) |
1 (1%) |
1 (2%) |
|
3 (2%) |
Opiates
|
Never |
49(88%) |
64 (72%) |
40 (83%) |
χ2(6, 193) = 8.36, p = .21 |
153 (79%) |
1–10x |
5(9%) |
19 (21%) |
5 (10%) |
|
29 (15%) |
11–50x |
2(4%) |
4 (5%) |
3 (6%) |
|
9 (5%) |
51–100x |
0(0%) |
2 (2%) |
0 (0%) |
|
2 (1%) |
Hallucinogens
|
Never |
40 (73%) |
50 (56%) |
35 (73%) |
χ2(6, 193) = 7.29, p = .30 |
125 (65%) |
1–10x |
13 (24%) |
34 (38%) |
10 (21%) |
|
57 (30%) |
11–50x |
2 (4%) |
4 (5%) |
2 (4%) |
|
8 (4%) |
51–100x |
0 (0%) |
1 (1%) |
1 (2%) |
|
2 (1%) |
Other Drugs
|
Never |
49 (89%) |
81 (91%) |
43 (90%) |
χ2(4, 193) = 3.12, p = .54 |
173 (90%) |
1–10x |
4 (7%) |
8 (9%) |
4 (8%) |
|
16 (8%) |
11–50x |
2 (4%) |
0 (0%) |
1 (2%) |
|
3 (2%) |